Product Code: ETC340860 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The Georgia pneumonia vaccine market is experiencing steady growth driven by the increasing prevalence of pneumonia and the government`s efforts to improve immunization coverage. Pneumonia is a significant cause of morbidity and mortality, particularly among children and the elderly. Vaccination against pneumococcal bacteria, the leading cause of pneumonia, is considered a cost-effective preventive measure. With initiatives to expand vaccination programs and raise awareness about the importance of immunization, Georgia healthcare sector is witnessing growing demand for pneumonia vaccines, driving market expansion and accessibility.
The Georgia Pneumonia Vaccine Market is witnessing growth driven by factors such as increasing awareness of the importance of vaccination, government initiatives to prevent infectious diseases, and the high prevalence of pneumonia in certain population groups. Pneumonia vaccines protect against bacterial and viral infections that can cause pneumonia, a leading cause of morbidity and mortality worldwide. With the growing emphasis on preventive healthcare and immunization programs in Georgia, the demand for pneumonia vaccines is expected to rise as healthcare providers and policymakers prioritize disease prevention and public health promotion efforts.
The Georgia pneumonia vaccine market faces challenges related to access and affordability. Pneumonia is a significant public health concern, causing substantial morbidity and mortality worldwide, particularly among vulnerable populations such as children and the elderly. However, ensuring equitable access to pneumonia vaccines, particularly in low- and middle-income countries, remains a challenge due to factors such as supply chain constraints, vaccine hesitancy, and funding limitations. Moreover, addressing the affordability of vaccines and reducing disparities in immunization coverage requires collaboration between governments, healthcare providers, and international organizations to implement sustainable vaccination strategies and health policies.
The government of Georgia recognizes the importance of vaccination in public health and disease prevention. Policies aimed at promoting immunization coverage support the availability and affordability of pneumonia vaccines. Through vaccination programs and healthcare infrastructure investments, the government seeks to reduce the burden of pneumonia and improve health outcomes for the population.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Georgia Pneumonia Vaccine Market Overview |
3.1 Georgia Country Macro Economic Indicators |
3.2 Georgia Pneumonia Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Georgia Pneumonia Vaccine Market - Industry Life Cycle |
3.4 Georgia Pneumonia Vaccine Market - Porter's Five Forces |
3.5 Georgia Pneumonia Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Georgia Pneumonia Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Georgia Pneumonia Vaccine Market Revenues & Volume Share, By Sector, 2021 & 2031F |
3.8 Georgia Pneumonia Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Georgia Pneumonia Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing pneumonia |
4.2.2 Growing government initiatives for immunization programs |
4.2.3 Rising incidences of pneumonia cases in Georgia |
4.3 Market Restraints |
4.3.1 High cost associated with pneumonia vaccines |
4.3.2 Limited access to healthcare facilities in remote areas of Georgia |
4.3.3 Concerns about the safety and efficacy of pneumonia vaccines |
5 Georgia Pneumonia Vaccine Market Trends |
6 Georgia Pneumonia Vaccine Market, By Types |
6.1 Georgia Pneumonia Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Georgia Pneumonia Vaccine Market Revenues & Volume, By Vaccine Type, 2021-2031F |
6.1.3 Georgia Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021-2031F |
6.1.4 Georgia Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021-2031F |
6.2 Georgia Pneumonia Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Georgia Pneumonia Vaccine Market Revenues & Volume, By Prevnar 13, 2021-2031F |
6.2.3 Georgia Pneumonia Vaccine Market Revenues & Volume, By Synflorix, 2021-2031F |
6.2.4 Georgia Pneumonia Vaccine Market Revenues & Volume, By Pneumovax 23, 2021-2031F |
6.3 Georgia Pneumonia Vaccine Market, By Sector |
6.3.1 Overview and Analysis |
6.3.2 Georgia Pneumonia Vaccine Market Revenues & Volume, By Public, 2021-2031F |
6.3.3 Georgia Pneumonia Vaccine Market Revenues & Volume, By Private, 2021-2031F |
6.4 Georgia Pneumonia Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Georgia Pneumonia Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021-2031F |
6.4.3 Georgia Pneumonia Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021-2031F |
6.4.4 Georgia Pneumonia Vaccine Market Revenues & Volume, By Government Authorities, 2021-2031F |
7 Georgia Pneumonia Vaccine Market Import-Export Trade Statistics |
7.1 Georgia Pneumonia Vaccine Market Export to Major Countries |
7.2 Georgia Pneumonia Vaccine Market Imports from Major Countries |
8 Georgia Pneumonia Vaccine Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates in Georgia |
8.2 Number of immunization campaigns conducted in the region |
8.3 Rate of decline in pneumonia cases among vaccinated population |
9 Georgia Pneumonia Vaccine Market - Opportunity Assessment |
9.1 Georgia Pneumonia Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Georgia Pneumonia Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Georgia Pneumonia Vaccine Market Opportunity Assessment, By Sector, 2021 & 2031F |
9.4 Georgia Pneumonia Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Georgia Pneumonia Vaccine Market - Competitive Landscape |
10.1 Georgia Pneumonia Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Georgia Pneumonia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |